UNIGE document Scientific Article
previous document  unige:90663  next document
add to browser collection
Title

Mechanisms of HIV receptor and co-receptor down-regulation by prostratin: role of conventional and novel PKC isoforms

Authors
Hezareh, Marjan
Szanto, Ildiko
Pondarzewski, Malgorzata
Brown, Stephen J
show hidden authors show all authors [1 - 9]
Published in Antiviral Chemistry and Chemotherapy. 2004, vol. 15, no. 4, p. 207-22
Abstract Prostratin is an unusual non-tumour promoting phorbol ester with potential as an inductive adjuvant therapy for highly active antiretroviral therapy (HAART) due to its ability to up-regulate viral expression from latent provirus. In addition, prostratin is also able to inhibit de novo HIV infection most probably because it induces down-regulation of HIV receptors from the surface of target cells. In this study, we investigate the mechanisms by which prostratin down-regulates HIV receptor and co-receptor surface expression in lymphocytic and monocytic cell lines. Our results indicate that prostratin induces down-regulation of surface expression of CD4 and CXCR4, but not CCR5, in various cell lines. Down-regulation of CD4 and CXCR4 by prostratin is achieved by internalization through receptor-mediated endocytosis and/or macropinocytosis, which is then followed by degradation of these molecules. Because prostratin is a protein kinase C (PKC) activator, we next examined the potential contribution of distinct PKC isoforms to down-regulate CD4 and CXCR4 in response to prostratin stimulation. Although exposure of cells to prostratin or phorbol-myristate-acetate (PMA) induces the translocation of several PKC isoforms to the plasma membrane, the use of specific PKC inhibitors revealed that novel PKCs are the main mediators of the prostratin-induced CD4 down-regulation, whereas both conventional and novel PKCs contribute to CXCR4 down-regulation. Altogether these results showed that prostratin, through the activation of conventional and/or novel PKC isoforms, rapidly reduces cell surface expression of CD4 and CXCR4, but not CCR5, by inducing their internalization and degradation.
Keywords AntigensCD4/metabolismCell LineDown-Regulation/drug effectsEndocytosis/drug effectsEnzyme Inhibitors/pharmacologyHumansIsoenzymes/antagonists & inhibitors/metabolismPhorbol Esters/pharmacologyProtein Kinase C/antagonists & inhibitors/metabolismProtein Transport/drug effectsReceptorsCCR5/metabolismReceptorsCXCR4/metabolismReceptorsHIV/metabolismT-Lymphocytes/drug effects/metabolismTetradecanoylphorbol Acetate/pharmacology
Identifiers
PMID: 15457682
Full text
Article (Published version) (409 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group Obésité et syndrome métabolique (803)
Citation
(ISO format)
HEZAREH, Marjan et al. Mechanisms of HIV receptor and co-receptor down-regulation by prostratin: role of conventional and novel PKC isoforms. In: Antiviral Chemistry and Chemotherapy, 2004, vol. 15, n° 4, p. 207-22. https://archive-ouverte.unige.ch/unige:90663

19 hits

0 download

Update

Deposited on : 2016-12-21

Export document
Format :
Citation style :